BRBI vs BSVN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits weak financial health with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score, raising concerns about bankruptcy risk assessment. Despite a high ROE of 20.85% and a dividend yield of 21.16%, the stock appears overvalued relative to both the Graham Number ($6.63) and Intrinsic Value ($9.38), trading at $14.39. Profitability metrics are distorted by a 101.45% operating margin and zero gross/profit margins, suggesting non-operational income dominance. Coupled with negative earnings growth, high debt/equity of 18.65, and bearish technical trends, the fundamental outlook remains fragile.
BSVN shows bullish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Key strengths include strong valuation and growth metrics. Price trades at a 30.2% premium to fair value estimate ($31.99), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BRBI vs BSVN: Head-to-Head Comparison
This page compares BRBI BR Partners S.A. (BRBI) and Bank7 Corp. (BSVN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.